Literature DB >> 28281220

The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.

Nicole J Flynn1,2, Rajasekharan Somasundaram3, Kimberly M Arnold1,4, Jennifer Sims-Mourtada5,6,7.   

Abstract

The influence of tumor infiltrating lymphocytes on tumor growth and response to therapy is becoming increasingly apparent. While much work has focused on the role of T cell responses in anti-tumor immunity, the role of B cells in solid tumors is much less understood. Tumor infiltrating B cells have been found in a variety of solid tumors, including breast, ovarian, prostate, melanoma, and colorectal cancer. The function of B cells in solid tumors is controversial, with many studies reporting a pro-tumor effect, while other studies demonstrate a role for B cells in the anti-tumor immune response. In this review, we discuss the prognostic ability of B cells in solid tumors as well as the mechanisms by which B cells can either promote or suppress anti-tumor immunity. Additionally, we review current therapeutic strategies that may target both pro- and anti-tumor B cells.

Entities:  

Mesh:

Year:  2017        PMID: 28281220     DOI: 10.1007/s11523-017-0481-x

Source DB:  PubMed          Journal:  Target Oncol        ISSN: 1776-2596            Impact factor:   4.864


  167 in total

1.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

Review 3.  Human B cell subsets.

Authors:  Stephen M Jackson; Patrick C Wilson; Judith A James; J Donald Capra
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

4.  Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.

Authors:  Kanika Garg; Margarita Maurer; Johannes Griss; Marie-Charlotte Brüggen; Ingrid H Wolf; Christine Wagner; Niels Willi; Kirsten D Mertz; Stephan N Wagner
Journal:  Hum Pathol       Date:  2016-04-21       Impact factor: 3.466

5.  Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE.

Authors:  Eva-Maria Varga; Fahima Kausar; Werner Aberer; Maximilian Zach; Ernst Eber; Stephen R Durham; Mohamed H Shamji
Journal:  J Allergy Clin Immunol       Date:  2012-10-11       Impact factor: 10.793

6.  Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients.

Authors:  M H Hansen; B Ostenstad; M Sioud
Journal:  Mol Med       Date:  2001-04       Impact factor: 6.354

7.  The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Authors:  Tamar Tadmor; Yu Zhang; Hyun-Mi Cho; Eckhard R Podack; Joseph D Rosenblatt
Journal:  Cancer Immunol Immunother       Date:  2011-01-21       Impact factor: 6.968

8.  Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers.

Authors:  Y Wang; F Ylera; M Boston; S-G Kang; J L Kutok; A J P Klein-Szanto; R P Junghans
Journal:  Breast Cancer Res Treat       Date:  2007-03-28       Impact factor: 4.872

9.  Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients.

Authors:  Xin Wei; Yangqiu Jin; Yinpu Tian; Huiyuan Zhang; Jie Wu; Wei Lu; Xiaofen Lu
Journal:  Tumour Biol       Date:  2015-12-05

10.  Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.

Authors:  David R Kroeger; Katy Milne; Brad H Nelson
Journal:  Clin Cancer Res       Date:  2016-01-13       Impact factor: 12.531

View more
  16 in total

1.  The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.

Authors:  Fereshteh Mehdipour; Mahboobeh Razmkhah; Zahra Faghih; Mandana Bagheri; Abdol-Rasoul Talei; Abbas Ghaderi
Journal:  Cell Oncol (Dordr)       Date:  2019-03-08       Impact factor: 6.730

Review 2.  [B cells in head and neck oncology].

Authors:  P J Schuler; C Brunner; T K Hoffmann
Journal:  HNO       Date:  2018-04       Impact factor: 1.284

Review 3.  B cells and antibody production in melanoma.

Authors:  Jessica Da Gama Duarte; Janique M Peyper; Jonathan M Blackburn
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

4.  Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1.

Authors:  Jiajing Liu; Yifan Li; Zhou Lu; Jie Gu; Yun Liang; Enyu Huang; Zhiming Wang; Hushan Zhang; Luman Wang; Dan Zhang; Hongxiu Yu; Ronghua Liu; Yiwei Chu
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

5.  Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.

Authors:  Jhalak Dholakia; Carly B Scalise; Ashwini A Katre; Whitney N Goldsberry; Selene Meza-Perez; Troy D Randall; Lyse A Norian; Lea Novak; Rebecca C Arend
Journal:  Gynecol Oncol       Date:  2021-11-26       Impact factor: 5.304

Review 6.  Immune crosstalk in cancer progression and metastatic spread: a complex conversation.

Authors:  Hannah Garner; Karin E de Visser
Journal:  Nat Rev Immunol       Date:  2020-02-05       Impact factor: 53.106

7.  The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma.

Authors:  Andreas Ziebart; Ulrich Huber; Sandra Jeske; Simon Laban; Johannes Doescher; Thomas K Hoffmann; Cornelia Brunner; Edwin K Jackson; Patrick J Schuler
Journal:  Oncotarget       Date:  2017-12-20

8.  Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages.

Authors:  Evangelia Goulielmaki; Miriam Bermudez-Brito; Margarita Andreou; Niki Tzenaki; Maria Tzardi; Eelco de Bree; Eleftheria Tsentelierou; Antonis Makrigiannakis; Evangelia A Papakonstanti
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

Review 9.  Obesity, Inflammation, and Prostate Cancer.

Authors:  Kazutoshi Fujita; Takuji Hayashi; Makoto Matsushita; Motohide Uemura; Norio Nonomura
Journal:  J Clin Med       Date:  2019-02-06       Impact factor: 4.241

Review 10.  Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses.

Authors:  Han Huang; Jiansong Fang; Xiude Fan; Tatsunori Miyata; Xiaoyue Hu; Lihe Zhang; Liangren Zhang; Yimin Cui; Zhenming Liu; Xiaoqin Wu
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.